Arylalkyl and heteroarylalkyl derivatives of cyclosporine A for the treatment and prevention of viral infection
US8329658B2 · kind B2 · utility
1Cited by
25References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 2, 2006 |
| Grant date | Dec 11, 2012 |
| Priority date | — |
| Expiry date | Sep 6, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention provides compounds of general formula (I):wherein A, B, R1, R2 and X are as defined in the specification, and pharmaceutical compositions prepared from the same, for use in treatment of hepatitis C virus and/or human immunodeficiency virus.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.